Top US trade negotiator meets Pfizer, AstraZeneca execs on Covid-19 IP waiver
Top US trade negotiator meets Pfizer, AstraZeneca execs on Covid-19 IP waiver
Democratic lawmakers, civil society groups, and 60 former heads of state and 100 Nobel Prize winners have urged President Joe Biden to back the waiver.
advertisement
UPDATED: April 27, 2021 09:24 IST
Katherine Tai, nominee for US Trade Representative speaks at the Senate Finance Committee hearing at the US Capitol in Washington, DC (Reuters)
US Trade Representative Katherine Tai on Monday met virtually with top executives of drugmakers Pfizer and AstraZeneca PLC to discuss a proposed waiver of certain intellectual property rights in response to the Covid-19 pandemic.
The US Trade Representative (USTR) Katherine Tai met top vaccine makers to discuss the proposed waivers to some provisions of the World Trade Organization’s (WTO’s) Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement in light of Covid-19. “Earlier today, Ambassador Tai continued her engagement with stakeholders on vaccine production and global health issues. She met virtually with executives from Pfizer and AstraZeneca about increasing global vaccine production and the proposed TRIPS waiver. Tai emphasised her commitment to working with WTO members on a global pandemic response that addresses critical gaps in global vaccine production and distribution,” a USTR spokesperson said in a tweet on Tuesday. The development comes a day after US President Joe Biden said he is determined to help India in its time of need.
SC asks Centre to clarify on Covid vaccine pricing; consider invoking Patent Act
SC asks Centre to clarify on Covid vaccine pricing; consider invoking Patent Act
Stating that the record spike in Covid-19 cases in India a “national crisis”, the Supreme Court on Tuesday said it cannot remain as a “mute spectator”.
advertisement
UPDATED: April 27, 2021 19:24 IST
The Centre has also been asked to inform about the modalities planned to ensure there will not be any shortage or deficit of vaccines
As the country inches towards vaccinating all between the age of 18 and 45, the SC on Tuesday asked the Union of India (UoI) to explain the basis and rationale adopted with
US Rep Tai discusses increasing vaccine production sierraleonetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sierraleonetimes.com Daily Mail and Mail on Sunday newspapers.
Commission, industry dubious about IP rights waiver for COVID-19 vaccines euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.